Exploration of potential inhibitors for tuberculosis via structure‐based drug design, molecular docking, and molecular dynamics simulation studies
Authors:
- 2 July 2021
- journal article
- research article
- Published by Wiley in Journal of Computational Chemistry
- Vol. 42 (24) , 1736-1749
Abstract
Drug resistance in tuberculosis is major threat to human population. In the present investigation, we aimed to identify novel and potent benzimidazole molecules to overcome the resistance management. A series of 20 benzimidazole derivatives were examined for its activity as selective antitubercular agents. Initially, AutodockVina algorithm was performed to assess the efficacy of the molecules. The results are further enriched by redocking by means of Glide algorithm. The binding free energies of the compounds were then calculated by MM‐generalized‐born surface area method. Molecular docking studies elucidated that benzimidazole derivatives has revealed formation of hydrogen bond and strong binding affinity in the active site of Mycobacterium tuberculosis protein. Note that ARG308, GLY189, VAL312, LEU403, and LEU190 amino acid residues of Mycobacterium tuberculosis protein PrpR are involved in binding with ligands of benzimidazoles. Interestingly, the ligands exhibited same binding potential to the active site of protein complex PrpR in both the docking programs. In essence, the result portrays that benzimidazole derivatives such as 1p, 1q, and 1 t could be potent and selective antitubercular agents than the standard drug isoniazid. These compounds were then subjected to molecular dynamics simulation to validate the dynamics activity of the compounds against PrpR. Finally, the inhibitory behavior of compounds was predicted using a machine learning algorithm trained on a data collection of 15,000 compounds utilizing graph‐based signatures. Overall, the study concludes that designed benzimidazoles can be employed as antitubercular agents. Indeed, the results are helpful for the experimental biologists to develop safe and non‐toxic drugs against tuberculosis.Keywords
Funding Information
- Taneja College of Pharmacy, University of South Florida
- VIT University
This publication has 52 references indexed in Scilit:
- Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugsJournal of the American Medical Informatics Association, 2012
- Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agentsBioorganic & Medicinal Chemistry Letters, 2011
- Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSAJournal of Computational Chemistry, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Clubbed [1,2,3] triazoles by fluorine benzimidazole: A novel approach to H37Rv inhibitors as a potential treatment for tuberculosisBioorganic & Medicinal Chemistry Letters, 2008
- Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol-2-amine and 4-methyl-2H-1,2,4-triazole-3(4H)-thione derivatives of benzimidazole classBioorganic & Medicinal Chemistry, 2008
- Drug—target networkNature Biotechnology, 2007
- Application of descriptors based on Lipinski’s rules in the QSPR study of aqueous solubilitiesBioorganic & Medicinal Chemistry, 2007
- The history of tuberculosisRespiratory Medicine, 2006